Thermo Fisher Scientific Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-06-27 | 2026-03-28 | 2025-12-31 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11.99B | 11.01B | 12.21B | 11.12B | 10.86B | 10.36B | 11.39B | 10.60B |
| Cost of Goods Sold | 7.05B | 6.53B | 7.58B | 6.47B | 6.81B | 6.12B | 6.93B | 6.25B |
| Gross Profit | 4.94B | 4.48B | 4.64B | 4.65B | 4.05B | 4.25B | 4.47B | 4.34B |
| R&D Expenses | 364.0M | 336.0M | 357.0M | 347.0M | 352.0M | 342.0M | 374.0M | 346.0M |
| Operating Expenses | 2.86B | 2.61B | 2.33B | 2.71B | 2.13B | 2.40B | 2.20B | 2.43B |
| Operating Income | 2.09B | 1.86B | 2.30B | 1.94B | 1.92B | 1.84B | 2.27B | 1.92B |
| Other Income / Gains | -163.0M | -129.0M | -179.0M | -115.0M | -206.0M | -234.0M | -294.0M | -188.0M |
| Net Income | 1.74B | 1.65B | 1.98B | 1.62B | 1.62B | 1.51B | 1.83B | 1.63B |
| EPS (Diluted) | 4.68 | 4.44 | 5.22 | 4.28 | 4.28 | 3.99 | 4.79 | 4.27 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.412 | 0.407 | 0.38 | 0.418 | 0.373 | 0.41 | 0.392 | 0.41 |
| General And Administrative Expenses | 1.91B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 1.91B | 1.80B | 1.98B | 2.37B | 1.78B | 2.06B | 1.82B | 2.08B |
| Other Expenses | 583.0M | 479.0M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 9.91B | 9.14B | 9.91B | 9.18B | 8.94B | 8.52B | 9.13B | 8.68B |
| Interest Income | 207.0M | 233.0M | 258.0M | 234.0M | 297.0M | 203.0M | 227.0M | 277.0M |
| Interest Expense | 401.0M | 354.0M | 365.0M | 347.0M | 404.0M | 303.0M | 384.0M | 424.0M |
| Depreciation And Amortization | 485.0M | 430.0M | 727.0M | 663.0M | 685.0M | 705.0M | 742.0M | 740.0M |
| Ebitda | 2.57B | 2.31B | 3.21B | 2.84B | 2.80B | 2.63B | 3.07B | 2.91B |
| Ebitdaratio | 0.214 | 0.21 | 0.263 | 0.255 | 0.258 | 0.254 | 0.269 | 0.274 |
| Operating Income Ratio | 0.174 | 0.169 | 0.188 | 0.175 | 0.177 | 0.178 | 0.199 | 0.181 |
| Income Before Tax | 1.92B | 1.73B | 2.12B | 1.83B | 1.71B | 1.61B | 1.97B | 1.73B |
| Income Before Tax Ratio | 0.16 | 0.158 | 0.174 | 0.164 | 0.158 | 0.155 | 0.173 | 0.163 |
| Income Tax Expense | 167.0M | 70.0M | 153.0M | 207.0M | 92.0M | 95.0M | 150.0M | 99.0M |
| Net Income Ratio | 0.145 | 0.15 | 0.162 | 0.145 | 0.149 | 0.145 | 0.161 | 0.154 |
| Epsdiluted | 4.68 | 4.43 | 5.21 | 4.27 | 4.28 | 3.98 | 4.78 | 4.24 |
| Weighted Average Shs Out | 371.0M | 372.0M | 376.0M | 378.0M | 378.0M | 378.0M | 382.8M | 382.0M |
| Weighted Average Shs Out Dil | 371.0M | 373.0M | 377.0M | 378.0M | 378.0M | 379.0M | 383.0M | 384.0M |